Acute coronary events following cisplatin-based chemotherapy

Six patients with no previous signs or symptom suggestive of coronary artery disease developed acute coronary ischemia/infarction shortly after cisdiaminedi-chloroplatinum II (cisplatin) -based chemotherapy. In two patients this was the sole chemotherapeutic agent used. One patient underwent coronary angiography which disclosed no pathology, but following which, while on a calcium channel blocking agent regimen, he had an uneventful course of chemotherapy with cisplatin. Documentation of cisplatin-related vascular events is important in view of the growing number of patients who undergo cisplatin-based chemotherapy.